Inventor · disambiguated record
Chandrasekar Venkataramani
Also filed as: VENKATARAMANI CHANDRASEKAR
60 granted patents·9 pending applications·361 citations·filing 2006–2025
98Inventor score
Files withGILEAD SCIENCES INC43GRAUPE MICHAEL4MELVIN JR LAWRENCE S4PORTOLA PHARM INC4CORKEY BRITTON KENNETH3
Top patents by PatentIndex Score
69 records- 0197US10988451B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Apr 27, 2021·10 cites·21 claims
- 0297US8138339B2Inhibitors of protein kinasesBAUER SHAWN M·Filed 2009·Granted Mar 20, 2012·63 cites·19 claims
- 0396US11643400B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2021·Granted May 9, 2023·4 cites·20 claims
- 0496US11584738B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Feb 21, 2023·11 cites·47 claims
- 0596US10703733B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2019·Granted Jul 7, 2020·12 cites·27 claims
- 0695US8575353B2Compounds for the treatment of addictionGILEAD SCIENCES INC·Filed 2013·Granted Nov 5, 2013·23 cites·26 claims
- 0794US11702407B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Jul 18, 2023·5 cites·26 claims
- 0894US11548871B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Jan 10, 2023·3 cites·30 claims
- 0994US8586732B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Nov 19, 2013·29 cites·35 claims
- 1094US8501944B2Inhibitors of protein kinasesBAUER SHAWN M·Filed 2012·Granted Aug 6, 2013·19 cites·2 claims
- 1194US8349860B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2011·Granted Jan 8, 2013·9 cites·2 claims
- 1294US8318755B2Inhibitors of SYK and JAK protein kinasesJIA ZHAOZHONG J·Filed 2011·Granted Nov 27, 2012·10 cites·2 claims
- 1394US8063058B2Inhibitors of syk and JAK protein kinasesJIA ZHAOZHONG J·Filed 2009·Granted Nov 22, 2011·14 cites·17 claims
- 1492US11897862B2IKAROS zinc finger family degraders and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Feb 13, 2024·2 cites·10 claims
- 1592US11667652B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jun 6, 2023·2 cites·15 claims
- 1692US8952027B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2012·Granted Feb 10, 2015·6 cites·21 claims
- 1792US8697863B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Apr 15, 2014·13 cites·11 claims
- 1891US9676760B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·7 cites·2 claims
- 1991US9610299B2Compounds for the treatment of addictionGILEAD SCIENCES INC·Filed 2015·Granted Apr 4, 2017·8 cites·3 claims
- 2091US9598435B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 21, 2017·9 cites·13 claims
- 2191US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 2290US9193694B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Nov 24, 2015·11 cites·11 claims
- 2390US9000015B2Compounds for the treatment of addictionGILEAD SCIENCES INC·Filed 2013·Granted Apr 7, 2015·9 cites·4 claims
- 2488US10533001B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2017·Granted Jan 14, 2020·4 cites·13 claims
- 2588US10040781B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Aug 7, 2018·3 cites·48 claims
- 2687US2025154116A1Mcl-1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2784US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 2884US8558001B2Compounds for the treatment of addictionCANNIZZARO CARINA E·Filed 2012·Granted Oct 15, 2013·8 cites·3 claims
- 2983US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 3083US9987295B2Compounds for the treatment of addictionAMYGDALA NEUROSCIENCES INC·Filed 2017·Granted Jun 5, 2018·3 cites·18 claims
- 3182US12162844B2MCL-1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Dec 10, 2024·0 cites·14 claims
- 3282US8962610B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Feb 24, 2015·6 cites·21 claims
- 3381US10072001B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Sep 11, 2018·3 cites·30 claims
- 3481US9115096B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Aug 25, 2015·5 cites·13 claims
- 3581US8198299B2Cycloalkylidene and heterocycloalkylidene inhibitor compoundsMELVIN JR LAWRENCE S·Filed 2011·Granted Jun 12, 2012·6 cites·22 claims
- 3681US7608592B2HCV inhibitorsVIROBAY INC·Filed 2006·Granted Oct 27, 2009·4 cites·31 claims
- 3781US2025197421A1Mcl1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3880US8673966B2ALDH-2 inhibitors in the treatment of addictionGRAUPE MICHAEL·Filed 2012·Granted Mar 18, 2014·5 cites·30 claims
- 3980US8088771B2Cycloalkylidene and heterocycloalkylidene inhibitor compoundsMELVIN JR LAWRENCE S·Filed 2009·Granted Jan 3, 2012·4 cites·9 claims
- 4079US11414410B2Inhibitors of protein kinasesALEXION PHARMA INC·Filed 2019·Granted Aug 16, 2022·0 cites·6 claims
- 4179US2025382278A1Ikaros zinc finger family degraders and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 4278US8344018B2Oxindolyl inhibitor compoundsGILEAD SCIENCES INC·Filed 2009·Granted Jan 1, 2013·3 cites·12 claims
- 4377US12202842B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Jan 21, 2025·0 cites·8 claims
- 4477US12139474B2LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Nov 12, 2024·0 cites·4 claims
- 4575US12358887B2IKAROS Zinc Finger Family degraders and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 15, 2025·0 cites·7 claims
- 4673US8258316B2Alkanoylamino benzamide aniline HDAC inhibitor compoundsGRAUPE MICHAEL·Filed 2010·Granted Sep 4, 2012·2 cites·17 claims
- 4772US11999717B2Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jun 4, 2024·0 cites·23 claims
- 4872US2025304554A1Lpa receptor antagonists and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 4970US9579320B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2014·Granted Feb 28, 2017·0 cites·3 claims
- 5067US2025230168A1Azaspiro wrn inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Chandrasekar Venkataramani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →